Category: News Well
Content tagged to appear in the middle column of the home page
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Lumicell says it received approval from the FDA for a pilot feasibility study of its intraoperative breast cancer imaging system.
Lumicell Diagnostics said it won an investigational device exemption from the FDA for a pilot feasibility trial of its imaging system for breast cancer surgeries.
The study is slated to be conducted at the Mass. General Hospital in Boston, the company said.
Private equity firm Warburg Pincus takes out a majority stake in contract sterilization company Sterigenics.
Private equity firm Warburg Pincus acquired a majority stake in contact sterilization provider Sterigenics International, according to GTCR, which bought the company in 2011.
On-X Life Technologies says it's launching a mitral valve chordal repair system, dubbed Chord-X.
On-X Life Technologies said it's launching Chord-X, a new mitral valve chordal repair system using the company's proprietary sutures.
Ocular Therapeutix says it's filing a new drug application with the FDA to broaden the indication for its flagship OTX-DB ocular pain drug, now named Dextenza.
NeuWave Medical raised more than $25 million in equity financing as it works to advance the market for its microwave ablation tumor removal tool.
NeuWave Medical – developer of a microwave ablation tumor removal tool – has pulled in more than $25.3 million in new equity financing.
Although it's a challenge for new medical device companies to arrange financing, there are funding opportunities out there for medtech startups willing to look beyond venture capital.
Financing for medtech startups can still be found, but the market climate is less than ideal, panelists at a LifeScience Alley conference said this week in Minneapolis.
The panel, "Financing Opportunities in Today's Marketplace," discussed venture capital, IPOs, strategic investors and the important role played by a board of directors play.